MRNA spotlight — 2026-10-06
MRNA saw a significant single-day increase of 6.95%, closing at $203.21 on Monday, October 5. This substantial move comes amidst a period of strong performance for the stock: over the past three months, MRNA has surged by 154.74%, and its…
Key figures
Data as of Oct 6, 2026- MRNA last close
- $203.21
- MRNA change vs prior close
- 6.95%
- MRNA market cap
- $80.68B
MRNA saw a significant single-day increase of 6.95%¹, closing at $203.21 on Monday, October 5². This substantial move comes amidst a period of strong performance for the stock: over the past three months, MRNA has surged by 154.74%³, and its market cap now stands at $80.68B⁴.
Despite this impressive growth, it's important to note that MRNA is not currently profitable; its latest reported EPS was -1.97⁵. This loss reframes the valuation of the company, as profitability has yet to materialize despite the recent surge in stock price.
MRNA’s current position is near its 52-week high at 96.9%⁶, and it currently trades well above both its 50-day average by 60.49%⁷ and its 200-day average by 193.43%⁸. The recent trading volume of 19,313,308 shares was also higher than the typical daily average at 1.33x⁹.
Recent news sentiment for MRNA has been mixed, with three positive articles and two negative ones out of six, suggesting ongoing interest and varied opinions about its future prospects.
Moderna, Inc. Common Stock (MRNA): price and news
Full chart and figuresEducational tool. Not investment advice. This article was produced with automated assistance. Every figure in it was checked against the underlying data before it was published; the interpretation was not.